ZYDUSLIFEZydus Lifesciences Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹1,149.00
▲ 0.46%Strong
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)1,13,077.00
P/E22.62
P/B4.21
PEG2.60
ROE %18.32
ROCE %14.60
Debt / Equity0.42
EPS50.12
Revenue Growth %16.20
Profit Growth %8.70
Dividend Yield %0.95
Promoter Holding %75.18
FII Holding %15.14
DII Holding %—
Beta0.40
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 80% | ₹1,149.00 | ₹1,126.60 | ₹1,203.90 | 2.45 |
BUYConviction 84%
Why buy
- • ROE: 18.3%
- • Debt/Equity: 0.42
- • Promoter holding: 75.2%
- • RSI: 60
- • Price vs EMA21: above
- • Price vs SMA50: above
- • Pullback to 21-EMA signal (setup quality 80%)
Bull case
- • ROE: 18.3%
- • Debt/Equity: 0.42
- • Promoter holding: 75.2%
- • RSI: 60
Bear case
- • Profit growth: 8.7% YoY
- • PEG ratio: 2.60
- • MACD: bearish
- • Volume: 0.7x 20-day average
Key risks
- • Profit growth: 8.7% YoY
- • PEG ratio: 2.60
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹1,149.00
Stop Loss
₹1,086.15
risk 5.5%
Target 1 (1.5R)
₹1,243.27
+8.2%
Target 2 (3R)
₹1,337.54
+16.4%
Support (20d)
₹1,087.30
Resistance (52w)
₹1,181.50
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹62.85/share
ATR (volatility)
₹25.14
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹25.14). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
67
Technical
71
Momentum
85
Risk (safety)
83